* Newly diagnosed or recurrent, mild to moderate Ulcerative Colitis patients.
* Extent of colonic involvement confirmed within the past 36 months
* UCDAI score of at least 3 but not greater than 8 and a score of at least 1 for endoscopy
* Screening tests to rule out any abnormalities in stool, heart or kidney.
* Male or non-pregnant females between 18 to 75 years.
* Women of childbearing potential to use efficacious contraception as judged by the investigator.
* Written informed consent given.
Inclusion Criteria for Maintenance phase:
* Newly recruited subjects with documented mild to moderate UC entering the Run-in Phase: in clinical remission for at least 1 month and for a maximum of 3 years, and receiving 5-ASA 1.4 to 2.5 g/day for maintenance of quiescent disease
* Subjects from Active Phase: meeting remission criteria after the 8-week active period
* Extent of colonic involvement confirmed within the past 36 months by colonoscopy
* In complete remission at entry into the Maintenance Phase, defined as i) a score of 0 or 1 for stool frequency; ii) a score of 0 for rectal bleeding; iii) a score of 0 for endoscopy findings; and iv) a Physician's Global Assessment (PGA) score of 0 or 1
* Screening tests to rule out any abnormalities in stool, heart or kidney.
Exclusion Criteria:
* Use of 5-ASA products at a dose \>2.5g/day within 7 days prior to entry.
* Proctitis, short bowel syndrome, prior bowel surgery, severe UC, other forms of Inflammatory Bowel Disease
* Infectious diseases, parasites, bacterial pathogens
* Allergy to aspirin or salicylate
* Liver or kidney abnormalities
* Alcohol or drug abuse
* Pregnancy
* Cancer
* Bleeding disorders, ulcers, autoimmune diseases
* Mental disorders
* Participation in clinical trial in last 30 days
* Inability to fill in diary cards / comply with protocol requirements
Source : Importé depuis le centre
Cohortes
Thérapie ou Intervention proposée
Cohortes
Nom
Condition médicale
Traitement
État du recrutement
Pentasa® modified extended release
Donnée non disponible
5-ASA (5-Aminosalicylate)
Inconnu
Pentasa®
Donnée non disponible
5-ASA (5-Aminosalicylate)
Inconnu
Pentasa® modified extended release
État du recrutement
unknown
5-ASA (5-Aminosalicylate)
Pentasa®
État du recrutement
unknown
5-ASA (5-Aminosalicylate)
Données à jour depuis :
20 avril 2016
Description de l'étude
Description de l'étude
Résumé de l'étude
The purpose of this study is to demonstrate that the new modified oral extended-release Pentasa® 500mg tablet is at least as efficacious as the currently marketed Pentasa® 500mg tablet in active mild to moderate Ulcerative Colitis (UC) and also in maintenance of quiescent disease.
Source : Importé depuis le centre
A multi-centre, randomized, double-blind, non-inferiority trial comparing the efficacy and safety of a new modified oral extended release Pentasa® (mesalamine) 500 mg tablet to the currently marketed Pentasa® (mesalamine) 500 mg tablet in subjects with active mild to moderate ulcerative colitis treated with 4 g/day for 8 weeks and in maintenance of remission of ulcerative colitis in subjects treated with 2 g/day for 24 weeks. The study involves male or non-pregnant female subjects aged 18 to 75 years.
Subjects were randomised on entry into the trial, and if they were in remission at the end of the 8-week Active Phase or the 4-week Run-in Phase, they were eligible for enrolment into the 24-week Maintenance Phase, remaining on the original randomised treatment.
Source : Importé depuis le centre
Centres participants
Sites
Centres participants
10
affichés
sur
27
centres
CENTRE HOSPITALIER UNIVERSITAIRE DE QUÉBEC
Québec
QUÉBEC, CANADA
Recrutement local
État du recrutement:
FERMÉ
CENTRE UNIVERSITAIRE DE SANTÉ MCGILL
Montréal
QUÉBEC, CANADA
Recrutement local
État du recrutement:
FERMÉ
ALPHA RECHERCHE CLINIQUE INC.
Loretteville
QUEBEC, CANADA
Recrutement local
État du recrutement:
FERMÉ
BARRIE GI ASSOCIATES
Barrie
ONTARIO, CANADA
Recrutement local
État du recrutement:
FERMÉ
CASTLEDOWNS MEDICENTRE
Edmonton
ALBERTA, CANADA
Recrutement local
État du recrutement:
FERMÉ
DIGESTIVE HEALTH CLINIC
Richmond hill
ONTARIO, CANADA
Recrutement local
État du recrutement:
FERMÉ
HILYARD PLACE BUILDING A
Saint john
NEW BRUNSWICK, CANADA
Recrutement local
État du recrutement:
FERMÉ
HOPITAL MAISSONNEUVE ROSEMONT
Montreal
QUEBEC, CANADA
Recrutement local
État du recrutement:
FERMÉ
HOTEL DIEU DE LEVIS
Levis
QUEBEC, CANADA
Recrutement local
État du recrutement:
FERMÉ
HOTEL DIEU GRACE HOSPITAL
Windsor
ONTARIO, CANADA
Recrutement local
État du recrutement:
FERMÉ
Centres participants
Source d'information
Dernière modification :
20 avril 2016
Données à jour depuis :
27 fév.
Origine des données :
clinicaltrials.gov